Clinical Trial Update: Survival and Dialysis Independency in Highly Sensitized Patients After Desensitization With Imlifidase and Tx of Kidneys

View source ↗

Summary

Update on survival and dialysis independence after desensitization with imlifidase followed by kidney transplantation in highly sensitized patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Imlifidase (imlifidase)

Snippet

Sponsor: Hansa Biopharma AB | Conditions: Kidney Transplantation in Highly Sensitized Patients | Status: ACTIVE_NOT_RECRUITING